# Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer

> **NCT00603538** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 19 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** CP-751,871 + carboplatin + paclitaxel

## Key facts

- **NCT ID:** NCT00603538
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2013-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603538, "Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00603538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*